Bridge Pharmaceuticals, Inc. (San Francisco, CA) an international contract research organization closed a Series B financing of $35M. The round was led by Granite Global Ventures.
Bridge Pharma, Inc.: Series B $35M
March 19, 2007
Leave a Comment » | 
I - Series B, R - WEST, X - CRO | 
Permalink
Posted by arubenstein
